Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4in activated murine macrophages: Implications in innate immunity

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 6136-6146

  Moreno, Cristina ^a   Prieto, Patricia ^a   Macías, Álvaro ^a   Pimentel Santillana, María ^a   De La Cruz, Alicia ^a   Través, Paqui G ^a   Boscá, Lisardo ^a,b   Valenzuela, Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; LIPOXIN A; LIPOXIN RECEPTOR; TRANSCRIPTION FACTOR NRF2; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; B LYMPHOCYTE; BONE MARROW DERIVED MACROPHAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROPHYSIOLOGICAL PROCEDURES; ENZYME ACTIVITY; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 84890357008     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300235     Document Type: Article

References (58)

1. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
2. Gordon, S. 2007. The macrophage: past, present and future. Eur. J. Immunol. 37 (Suppl 1): S9-S17.
3. Pasare, C., and R. Medzhitov. 2005. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560: 11-18.
4. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
5. Vicente, R., A. Escalada, M. Coma, G. Fuster, E. Sánchez- Tilló, C. López-Iglesias, C. Soler, C. Solsona, A. Celada, and A. Felipe. 2003. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J. Biol. Chem. 278: 46307-46320.
6. Cahalan, M. D., and K. G. Chandy. 1997. Ion channels in the immune system as targets for immunosuppression. Curr. Opin. Biotechnol. 8: 749-756.
7. Panyi, G., G. Vámosi, A. Bodnár, R. Gáspár, and S. Damjanovich. 2004. Looking through ion channels: recharged concepts in T-cell signaling. Trends Immunol. 25: 565-569.
8. Mantovani, A., C. Garlanda, and M. Locati. 2009. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 29: 1419-1423.
9. Bottazzi, B., A. Doni, C. Garlanda, and A. Mantovani. 2010. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu. Rev. Immunol. 28: 157-183.
10. Rodríguez-Prados, J. C., P. G. Través, J. Cuenca, D. Rico, J. Aragonés, P. Martín-Sanz, M. Cascante, and L. Boscá. 2010. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185: 605-614.
11. Gronert, K., A. Gewirtz, J. L. Madara, and C. N. Serhan. 1998. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J. Exp. Med. 187: 1285-1294.
12. Weber, C., and H. Noels. 2011. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17: 1410-1422.
13. Peña, J. M., J. MacFadyen, R. J. Glynn, and P. M. Ridker. 2012. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur. Heart J. 33: 531-537.
14. Sobirin, M. A., S. Kinugawa, M. Takahashi, A. Fukushima, T. Homma, T. Ono, K. Hirabayashi, T. Suga, P. Azalia, S. Takada, et al. 2012. Activation of natural killer T cells ameliorates postinfarct cardiac remodeling and failure in mice. Circ. Res. 111: 1037-1047.
15. Vicente, R., A. Escalada, N. Villalonga, L. Texidó, M. Roura-Ferrer, M. Martín-Satué, C. López-Iglesias, C. Soler, C. Solsona, M. M. Tamkun, and A. Felipe. 2006. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J. Biol. Chem. 281: 37675-37685.
16. Villalonga, N., M. David, J. Bielanska, R. Vicente, N. Comes, C. Valenzuela, and A. Felipe. 2010. Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences. J. Gen. Physiol. 135: 135-147.
17. Chen, M., M. Divangahi, H. Gan, D. S. Shin, S. Hong, D. M. Lee, C. N. Serhan, S. M. Behar, and H. G. Remold. 2008. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205: 2791-2801.
18. Ji, R. R., Z. Z. Xu, G. Strichartz, and C. N. Serhan. 2011. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci. 34: 599-609.
19. Serhan, C. N., J. Dalli, S. Karamnov, A. Choi, C. K. Park, Z. Z. Xu, R. R. Ji, M. Zhu, and N. A. Petasis. 2012. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26: 1755-1765.
20. Bannenberg, G., and C. N. Serhan. 2010. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta 1801: 1260-1273.
21. Serhan, C. N., S. Yacoubian, and R. Yang. 2008. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 3: 279-312.
22. Prieto, P., J. Cuenca, P. G. Través, M. Fernández-Velasco, P. Martín-Sanz, and L. Boscá. 2010. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ. 17: 1179-1188.
23. Serhan, C. N., N. Chiang, and T. E. Van Dyke. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8: 349-361.
24. Chiang, N., M. Arita, and C. N. Serhan. 2005. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot. Essent. Fatty Acids 73: 163-177.
25. Devchand, P. R., M. Arita, S. Hong, G. Bannenberg, R. L. Moussignac, K. Gronert, and C. N. Serhan. 2003. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17: 652-659.
26. Brancaleone, V., T. Gobbetti, N. Cenac, P. le Faouder, B. Colom, R. J. Flower, N. Vergnolle, S. Nourshargh, and M. Perretti. 2013. A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood 122: 608-617.
27. V1.5 channelosome. J. Biol. Chem. 287: 21416-21428.
28. Hortelano, S., M. Zeini, A. Castrillo, A. M. Alvarez, and L. Boscá. 2002. Induction of apoptosis by nitric oxide in macrophages is independent of apoptotic volume decrease. Cell Death Differ. 9: 643-650.
29. Través, P. G., M. Pimentel-Santillana, L. M. Carrasquero, R. Pérez-Sen, E. G. Delicado, A. Luque, M. Izquierdo, P. Martín-Sanz, M. T. Miras-Portugal, and L. Boscá. 2013. Selective impairment of P2Y signaling by prostaglandin E2 in macrophages: implications for Ca2+-dependent responses. J. Immunol. 190: 4226-4235.
30. Wisniewski, D., P. LoGrasso, J. Calaycay, and A. Marcy. 1999. Assay for IkappaB kinases using an in vivo biotinylated IkappaB protein substrate. Anal. Biochem. 274: 220-228.
31. Traves, P. G., S. Hortelano, M. Zeini, T. H. Chao, T. Lam, S. T. Neuteboom, E. A. Theodorakis, M. A. Palladino, A. Castrillo, and L. Bosca. 2007. Selective activation of liver X receptors by acanthoic acid-related diterpenes. Mol. Pharmacol. 71: 1545-1553.
32. Grissmer, S., and M. D. Cahalan. 1989. Divalent ion trapping inside potassium channels of human T lymphocytes. J. Gen. Physiol. 93: 609-630.
33. Gutman, G. A., K. G. Chandy, S. Grissmer, M. Lazdunski, D. McKinnon, L. A. Pardo, G. A. Robertson, B. Rudy, M. C. Sanguinetti, W. Stühmer, and X. Wang. 2005. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57: 473-508.
34. Maderna, P., D. C. Cottell, T. Toivonen, N. Dufton, J. Dalli, M. Perretti, and C. Godson. 2010. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis. FASEB J. 24: 4240-4249.
35. Maderna, P., and C. Godson. 2005. Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells. Prostaglandins Leukot. Essent. Fatty Acids 73: 179-187.
36. Souza, D. G., C. T. Fagundes, F. A. Amaral, D. Cisalpino, L. P. Sousa, A. T. Vieira, V. Pinho, J. R. Nicoli, L. Q. Vieira, I. M. Fierro, and M. M. Teixeira. 2007. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J. Immunol. 179: 8533-8543.
37. Sodin-Semrl, S., A. Spagnolo, B. Barbaro, J. Varga, and S. Fiore. 2004. Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes. Int. J. Immunopathol. Pharmacol. 17: 15-25.
38. Chandy, K. G., H. Wulff, C. Beeton, M. Pennington, G. A. Gutman, and M. D. Cahalan. 2004. K+ channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 25: 280-289.
39. Beeton, C., J. Barbaria, P. Giraud, J. Devaux, A. M. Benoliel, M. Gola, J. M. Sabatier, D. Bernard, M. Crest, and E. Béraud. 2001. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J. Immunol. 166: 936-944.
40. Beeton, C., M. W. Pennington, H. Wulff, S. Singh, D. Nugent, G. Crossley, I. Khaytin, P. A. Calabresi, C. Y. Chen, G. A. Gutman, and K. G. Chandy. 2005. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol. Pharmacol. 67: 1369-1381.
41. Beeton, C., H. Wulff, J. Barbaria, O. Clot-Faybesse, M. Pennington, D. Bernard, M. D. Cahalan, K. G. Chandy, and E. Béraud. 2001. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 98: 13942-13947.
42. Rus, H., C. A. Pardo, L. Hu, E. Darrah, C. Cudrici, T. Niculescu, F. Niculescu, K. M. Mullen, R. Allie, L. Guo, et al. 2005. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc. Natl. Acad. Sci. USA 102: 11094-11099.
43. DeCoursey, T. E., S. Y. Kim, M. R. Silver, and F. N. Quandt. 1996. Ion channel expression in PMA-differentiated human THP-1 macrophages. J. Membr. Biol. 152: 141-157.
44. Gallin, E. K. 1984. Calcium- and voltage-activated potassium channels in human macrophages. Biophys. J. 46: 821-825.
45. Kotecha, S. A., and L. C. Schlichter. 1999. A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation. J. Neurosci. 19: 10680-10693.
46. Schilling, T., F. N. Quandt, V. V. Cherny,W. Zhou, U. Heinemann, T. E. Decoursey, and C. Eder. 2000. Upregulation of Kv1.3 K(+) channels in microglia deactivated by TGF-beta. Am. J. Physiol. Cell Physiol. 279: C1123-C1134.
47. Ypey, D. L., and D. E. Clapham. 1984. Development of a delayed outward-rectifying K+ conductance in cultured mouse peritoneal macrophages. Proc. Natl. Acad. Sci. USA 81: 3083-3087.
48. Mackenzie, A. B., H. Chirakkal, and R. A. North. 2003. Kv1.3 potassium channels in human alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L862-L868.
49. Blunck, R., O. Scheel, M. Müller, K. Brandenburg, U. Seitzer, and U. Seydel. 2001. New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling. J. Immunol. 166: 1009-1015.
50. Khanna, R., L. Roy, X. Zhu, and L. C. Schlichter. 2001. K+ channels and the microglial respiratory burst. Am. J. Physiol. Cell Physiol. 280: C796-C806.
51. Berridge, M. J., P. Lipp, and M. D. Bootman. 2000. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1: 11-21.
52. Cahalan, M. D., and K. G. Chandy. 2009. The functional network of ion channels in T lymphocytes. Immunol. Rev. 231: 59-87.
53. Feske, S., Y. Gwack, M. Prakriya, S. Srikanth, S. H. Puppel, B. Tanasa, P. G. Hogan, R. S. Lewis, M. Daly, and A. Rao. 2006. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179-185.
54. Prakriya, M., S. Feske, Y. Gwack, S. Srikanth, A. Rao, and P. G. Hogan. 2006. Orai1 is an essential pore subunit of the CRAC channel. Nature 443: 230-233.
55. Vig, M., C. Peinelt, A. Beck, D. L. Koomoa, D. Rabah, M. Koblan-Huberson, S. Kraft, H. Turner, A. Fleig, R. Penner, and J. P. Kinet. 2006. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312: 1220-1223.
56. Yeromin, A. V., S. L. Zhang, W. Jiang, Y. Yu, O. Safrina, and M. D. Cahalan. 2006. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 443: 226-229.
57. Lin, C. S., R. C. Boltz, J. T. Blake, M. Nguyen, A. Talento, P. A. Fischer, M. S. Springer, N. H. Sigal, R. S. Slaughter, M. L. Garcia, et al. 1993. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J. Exp. Med. 177: 637-645.
58. Lampert, A., M. M. Müller, S. Berchtold, K. S. Lang, M. Palmada, O. Dobrovinskaya, and F. Lang. 2003. Effect of dexamethasone on voltage-gated K+ channels in Jurkat T-lymphocytes. Pflugers Arch. 447: 168-174.